|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02607 SH PHARMA
Nominal 
12.660 -0.180 (-1.402%) Ranking Overview
Ranking based on 8 research report(s)
Average Ranking 2.00
|
Strong Buy (1)
0
|
Buy (2)
8
|
Hold (3)
0
|
Sell (4)
0
|
Strong Sell (5)
0
|
Previous Financial Performance
| Financial Year | 12/2023 | EPS | 102.00 RMB (cts) | |
| Net Profit | 3,768.00 RMB (MIL) | DPS | 41.00 RMB (cts) |
Consolidation Estimation
| Financial Year | Profit / (Loss) (RMB (MIL)) |
EPS/ ((LPS)(RMB (cts)) |
DPS (RMB (cts)) |
Net Asset Value per Share (RMB) |
Highest (RMB (MIL)) |
Lowest (RMB (MIL)) |
| 2024 | 5,117.50 | 135.45 | 51.20 | -- | 6,459.00 | 4,170.00 |
| 2025 | 5,761.50 | 151.95 | 54.66 | -- | 6,957.00 | 4,517.00 |
| 2026 | 6,379.00 | 172.00 | 54.20 | -- | 6,841.00 | 4,918.00 |
Profit Estimation
| Profit Estimation | Profit / (Loss) (RMB (MIL)) |
EPS*/ (LPS) (RMB (cts)) |
DPS * (RMB (cts)) |
Broker | Ranking | Target Price* (HKD) |
Update Date | |
| 2024 | 5,225.00 | 141.00 | 57.00 | HSBC | Buy | 17.60 | 07/06/2024 | |
| 2024 | 5,209.00 | 141.00 | -- | CITIC SEC | Buy | 16.00 | 30/10/2024 | |
| 2024 | 5,069.00 | 136.90 | 41.10 | CITIGROUP | Buy | 15.30 | 11/11/2024 | |
| 2024 | 4,723.00 | 128.00 | 41.10 | UBS | Buy | 14.90 | 11/09/2024 | |
| 2024 | 4,810.00 | 130.00 | 78.00 | CICC | OutPerform | 14.70 | 28/07/2024 | |
| 2024 | 6,459.00 | 134.00 | -- | HAITONG | OutPerform | 13.82 | 02/09/2024 | |
| 2024 | 5,166.00 | 139.00 | 60.00 | CLSA | OutPerform | 13.80 | 31/10/2024 | |
| 2024 | 4,170.00 | 113.00 | 45.40 | BANK OF AMERICA | Buy | 13.70 | 27/08/2024 | |
| 2025 | 5,822.00 | 157.00 | 63.00 | HSBC | -- | -- | 07/06/2024 | |
| 2025 | 5,806.00 | 157.00 | -- | CITIC SEC | -- | -- | 30/10/2024 | |
| 2025 | 5,547.00 | 149.90 | 45.00 | CITIGROUP | -- | -- | 11/11/2024 | |
| 2025 | 5,717.00 | 154.00 | 49.32 | UBS | -- | -- | 11/09/2024 | |
| 2025 | 5,294.00 | 143.00 | 86.00 | CICC | -- | -- | 28/07/2024 | |
| 2025 | 6,957.00 | 145.00 | -- | HAITONG | -- | -- | 02/09/2024 | |
| 2025 | 5,834.00 | 158.00 | 60.00 | CLSA | -- | -- | 31/10/2024 | |
| 2025 | 4,517.00 | 122.00 | 49.20 | BANK OF AMERICA | -- | -- | 27/08/2024 | |
| 2026 | 6,407.00 | 173.00 | 70.00 | HSBC | -- | -- | 07/06/2024 | |
| 2026 | 6,510.00 | 176.00 | -- | CITIC SEC | -- | -- | 30/10/2024 | |
| 2026 | 6,149.00 | 166.10 | 49.90 | CITIGROUP | -- | -- | 11/11/2024 | |
| 2026 | 6,379.00 | 172.00 | 54.80 | UBS | -- | -- | 11/09/2024 | |
| 2026 | 6,276.00 | 170.00 | 50.00 | HAITONG | -- | -- | 26/07/2024 | |
| 2026 | 6,841.00 | 185.00 | 70.00 | CLSA | -- | -- | 31/10/2024 | |
| 2026 | 4,918.00 | 133.00 | 53.60 | BANK OF AMERICA | -- | -- | 27/08/2024 | |
| Remarks: | Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa. |
| *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue | |
| Real time quote last updated: 22/11/2024 17:59 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 2,941,911 |
| %Change | 12.725% |
| EPS / (LPS) | RMB 0.790 |
| NBV Per Share (¥) | RMB 18.898 |